| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 218 | 2021 |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 150 | 2022 |
| Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease R Younes, GP Caviglia, O Govaere, C Rosso, A Armandi, T Sanavia, ... Journal of hepatology 75 (4), 786-794, 2021 | 132 | 2021 |
| Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta … FE Mózes, JA Lee, Y Vali, O Alzoubi, K Staufer, M Trauner, R Paternostro, ... The Lancet Gastroenterology & Hepatology 8 (8), 704-713, 2023 | 67 | 2023 |
| Insulin resistance across the spectrum of nonalcoholic fatty liver disease A Armandi, C Rosso, GP Caviglia, E Bugianesi Metabolites 11 (3), 155, 2021 | 64 | 2021 |
| Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals C Saponaro, S Sabatini, M Gaggini, F Carli, C Rosso, V Positano, ... Liver International 42 (11), 2418-2427, 2022 | 42 | 2022 |
| On-treatment decrease of serum interleukin-6 as a predictor of clinical response to biologic therapy in patients with inflammatory bowel diseases GP Caviglia, C Rosso, F Stalla, M Rizzo, A Massano, ML Abate, A Olivero, ... Journal of Clinical Medicine 9 (3), 800, 2020 | 41 | 2020 |
| Alpha-fetoprotein, protein induced by vitamin K absence or antagonist II and glypican-3 for the detection and prediction of hepatocellular carcinoma in patients with cirrhosis … GP Caviglia, M Ciruolo, ML Abate, P Carucci, E Rolle, C Rosso, A Olivero, ... Cancers 12 (11), 3218, 2020 | 38 | 2020 |
| The impact of dysmetabolic sarcopenia among insulin sensitive tissues: a narrative review A Armandi, C Rosso, GP Caviglia, DG Ribaldone, E Bugianesi Frontiers in Endocrinology 12, 716533, 2021 | 33 | 2021 |
| Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease GP Caviglia, A Armandi, C Rosso, S Gaia, S Aneli, E Rolle, ML Abate, ... Cancers 13 (10), 2305, 2021 | 30 | 2021 |
| Beyond the paradigm of weight loss in non-alcoholic fatty liver disease: from pathophysiology to novel dietary approaches A Armandi, JM Schattenberg Nutrients 13 (6), 1977, 2021 | 27 | 2021 |
| Natural history of NASH A Armandi, E Bugianesi Liver International 41, 78-82, 2021 | 27 | 2021 |
| Clinical response and changes of cytokines and zonulin levels in patients with diarrhoea-predominant irritable bowel syndrome treated with Bifidobacterium Longum ES1 for 8 or … GP Caviglia, A Tucci, R Pellicano, S Fagoonee, C Rosso, ML Abate, ... Journal of Clinical Medicine 9 (8), 2353, 2020 | 27 | 2020 |
| Switching from biosimilar to biosimilar adalimumab, including multiple switching, in Crohn’s disease: a prospective study DG Ribaldone, E Tribocco, C Rosso, A Armandi, M Vernero, E Bugianesi, ... Journal of Clinical Medicine 10 (15), 3387, 2021 | 25 | 2021 |
| Inflammatory bowel disease nurse—practical messages C Rosso, AA Aaron, A Armandi, GP Caviglia, M Vernero, GM Saracco, ... Nursing Reports 11 (2), 229-241, 2021 | 24 | 2021 |
| Interplay between oxidative stress and metabolic derangements in non-alcoholic fatty liver disease: the role of selenoprotein P GP Caviglia, C Rosso, A Armandi, M Gaggini, F Carli, ML Abate, A Olivero, ... International Journal of Molecular Sciences 21 (22), 8838, 2020 | 22 | 2020 |
| Epidemiology of inflammatory bowel diseases: a population study in a healthcare district of North-West Italy GP Caviglia, A Garrone, C Bertolino, R Vanni, E Bretto, A Poshnjari, ... Journal of Clinical Medicine 12 (2), 641, 2023 | 20 | 2023 |
| Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany C Labenz, K Kostev, A Armandi, PR Galle, JM Schattenberg UEG Journal 9 (7), 829-836, 2021 | 19 | 2021 |
| Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV M Michel, C Labenz, A Wahl, M Anders, A Armandi, Y Huber, PR Galle, ... Aids 36 (12), 1665-1674, 2022 | 18 | 2022 |
| Crosstalk between irisin levels, liver fibrogenesis and liver damage in non-obese, non-diabetic individuals with non-alcoholic fatty liver disease A Armandi, C Rosso, A Nicolosi, GP Caviglia, ML Abate, A Olivero, ... Journal of Clinical Medicine 11 (3), 635, 2022 | 16 | 2022 |
